Biogen Inc.
DE ˙ DB ˙ US09062X1037
170,90 € ↑8,70 (5,36%)
2026-06-04
CENA AKCJI
SecurityDE:IDP / Biogen Inc.
InstitutionPflug Koory, LLC
Latest Disclosed Ownership464 shares
Latest Disclosed Value $ 85,065
Pflug Koory, LLC ownership in IDP / Biogen Inc.

On April 21, 2026 - Pflug Koory, LLC filed a 13F-HR form disclosing ownership of 464 shares of Biogen Inc. (DE:IDP) valued at $72,036 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 464 shares of Biogen Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $79,298 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F BIOGEN COM 09062X103 464 0 0.00 85 4.94 0.0390
2026-01-20 2025-12-31 13F BIOGEN COM 09062X103 464 0 0.00 82 26.56 0.0381
2025-10-21 2025-09-30 13F BIOGEN COM 09062X103 464 250 116.82 65 146.15 0.0308
2025-07-21 2025-06-30 13F BIOGEN COM 09062X103 214 0 0.00 27 -10.34 0.0136
2025-04-17 2025-03-31 13F BIOGEN COM 09062X103 214 0 0.00 29 -9.37 0.0163
2025-01-21 2024-12-31 13F BIOGEN COM 09062X103 214 -40 -15.75 33 -34.69 0.0166
2025-01-15 2024-09-30 13F BIOGEN COM 09062X103 254 16 6.72 49 -3.92 0.0242
2024-04-11 2024-03-31 13F BIOGEN COM 09062X103 238 0 0.00 51 -16.39 0.0252
2024-01-11 2023-12-31 13F BIOGEN COM 09062X103 238 55 30.05 62 29.79 0.0326
2023-10-30 2023-09-30 13F BIOGEN COM 09062X103 183 23 14.38 47 4.44 0.0272
2023-07-21 2023-06-30 13F BIOGEN COM 09062X103 160 0 0.00 46 2.27 0.0232
2023-04-20 2023-03-31 13F BIOGEN COM 09062X103 160 0 0.00 44 0.0242
2023-01-18 2022-12-31 13F BIOGEN COM 09062X103 160 0 0.00 0 -100.00 0.0245
2022-10-11 2022-09-30 13F BIOGEN COM 09062X103 160 0 0.00 43 30.30 0.0262
2022-08-01 2022-06-30 13F BIOGEN COM 09062X103 160 0 0.00 33 -2.94 0.0190
2022-04-14 2022-03-31 13F BIOGEN COM 09062X103 160 75 88.24 34 70.00 0.0171
2022-01-20 2021-12-31 13F BIOGEN COM 09062X103 85 28 49.12 20 25.00 0.0101
2021-10-19 2021-09-30 13F BIOGEN COM 09062X103 57 0 0.00 16 -20.00 0.0087
2021-07-14 2021-06-30 13F BIOGEN COM 09062X103 57 0 0.00 20 25.00 0.0105
2021-07-13 2021-03-31 13F BIOGEN COM 09062X103 57 0 0.00 16 14.29 0.0088
2021-01-14 2020-12-31 13F BIOGEN COM 09062X103 57 10 21.28 14 7.69 0.0083
2020-10-20 2020-09-30 13F BIOGEN COM 09062X103 47 0 0.00 13 0.00 0.0088
2020-07-30 2020-06-30 13F BIOGEN COM 09062X103 47 0 0.00 13 -13.33 0.0096
2020-04-24 2020-03-31 13F BIOGEN COM 09062X103 47 0 0.00 15 7.14 0.0133
2020-01-14 2019-12-31 13F BIOGEN COM 09062X103 47 10 27.03 14 55.56 0.0099
2019-10-15 2019-09-30 13F BIOGEN COM 09062X103 37 0 0.00 9 0.00 0.0068
2019-08-02 2019-06-30 13F BIOGEN COM 09062X103 37 0 0.00 9 0.00 0.0069
2019-04-11 2019-03-31 13F BIOGEN COM 09062X103 37 0 0.00 9 -18.18 0.0070
2019-01-24 2018-12-31 13F BIOGEN COM 09062X103 37 0 0.00 11 -15.38 0.0094
2018-11-06 2018-09-30 13F BIOGEN COM 09062X103 37 0 0.00 13 18.18 0.0105
2018-08-13 2018-06-30 13F BIOGEN COM 09062X103 37 12 48.00 11 57.14 0.0087
2018-08-13 2018-03-31 13F BIOGEN COM 09062X103 25 0 0.00 7 -12.50 0.0058
2018-08-13 2017-12-31 13F BIOGEN COM 09062X103 25 0 0.00 8 0.00 0.0063
2018-08-13 2017-09-30 13F BIOGEN COM 09062X103 25 0 0.00 8 14.29 0.0065
2018-08-13 2017-06-30 13F BIOGEN COM 09062X103 25 0 0.00 7 0.00 0.0059
2018-08-13 2017-03-31 13F BIOGEN COM 09062X103 25 25 7 0.0061
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.